The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
Top Cited Papers
- 1 August 2006
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 368 (9534), 505-510
- https://doi.org/10.1016/s0140-6736(06)69158-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in AfricaAIDS, 2006
- Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessmentThe Lancet, 2006
- Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesThe Lancet, 2006
- Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV‐Infected Antiretroviral‐Naive SubjectsThe Journal of Infectious Diseases, 2005
- British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005)HIV Medicine, 2005
- Public health in the new era: improving health through collective actionThe Lancet, 2004
- Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 InfectionThe New England Journal of Medicine, 2004
- Evaluation of microscope condition in MalawiTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000